Drug Utilization of Antimicrobial Agents in patients of Pelvic Inflammatory Disease attending Obstetrics & Gynaecology Department in a Tertiary Care Hospital

Authors

  • Tarak Nath Mukherjee Assistant Professor, Department of Obstetrics & Gynaecology, Adani Institute of Medical Science, Bhuj, Gujrat Author

DOI:

https://doi.org/10.21276/mem9tw15

Keywords:

Drug Utilization of Antimicrobial Agents

Abstract

Introduction: Pelvic inflammatory disease (PID) is a major health concern leading to profound gynecological morbidity among women in reproductive age group. Therefore, this study was undertaken to analyze the prescription pattern of Antimicrobial Agents in patients suffering from Pelvic Inflammatory Diseases.

Methodology: A cross-sectional study was conducted at the Department of Gynecology & Obstetrics of Adani Institute of Medical Science, Bhuj, Gujrat. A total of 442 prescriptions of clinically diagnosed PID cases from Outpatient Department (OPD) and Inpatient Department (IPD) were collected and analyzed in the department of Pharmacology on the basis of Drug utilization WHO indicators.

Results: Average number of AMAs per prescription was 2.0. Majority of patients were prescribed Antifungals (n=237, P=25.90%) followed by Nitroimidazoles (n=184, P=20.10%), Fluoroquinolones (n=182, P=19.89%), Doxycycline (n=166, P=18.14%), and least prescribed was Aminoglycoside and Urinary antiseptics (n=4, P=4.04%).

Conclusion: There was minimal difference between defined recommendations in standard treatment guidelines and the clinical use of antimicrobial agents. The only lacking part of this study was lesser use of generic drugs.

Downloads

Download data is not yet available.

References

Westrom L, Joesoef R, Reynolds G, Hagdu A, Thompson SE.

Pelvic inflammatory disease and fertility- A cohort study of 1,844

women with laparoscopically verified disease and 657 control

women with normal laparoscopic results. Sex Transm Dis 1992;

:185-92.

Aggarwal D. Reproductive tract infections - challenges and

responses; Health for the Millions 2001;3:21-3.

Bevan CD, Johal BJ, Mumtaz G, Ridgway GL, Siddle NC.

Clinical, laparoscopic and microbiological findings in acute

salpingitis: report on a United Kingdom cohort. British Journal

of Obstetrics & Gynaecology 1995; 102:407- 14.

Recommendations arising from the 31st Study Group: The

Prevention of Pelvic infection. in Templeton A, ed. The

prevention of pelvic, pp 267-70. London:RCOG Press, 1996.

Cohen CR, Manhart LE, Bukusi EA, Astete S, Brunham RC,

Holmes KK et al. Association between Mycoplasma genitalium

and acute endometritis. Lancet 2002; 359: 765-6.

Goldman DA, Weinstein RA, Wenzel RP. Strategies to prevent

and control the emergence of antimicrobial resistant microorganisms in hospital. JAMA. 1996;275:234-49.

Lesar TS, Briceland LL. Survey of antibiotic control policies in

university-affiliated teaching institutions. Ann Pharmacother.

;30:31-34.

Sharma S, Goel M, Sharma R. Drug utilization study in pelvic

inflammatory disease in a teaching hospital in North India.

International Journal of Pharmaceutical Research And Bioscience, 2013;2(4):152-167.

Basu J, Bhowmick S, Pal A et. al. Prescribing pattern of

antimicrobial agents in pelvic inflammatory disease at a rural

teaching hospital in India. Int J Health Sci Res. 2015; 5(8):316-

Saini S, Gupta N, Aparna, Batra G, Arora D R. Role of anaerobes

in acute pelvic inflammatory disease. Indian J Med Microbiol,

;21:18992

Downloads

Published

12.04.2024

Issue

Section

ORIGINAL ARTICLES ~ Obstetrics & Gynaecology

Similar Articles

1-10 of 104

You may also start an advanced similarity search for this article.